Literature DB >> 17521503

Heart transplantation: assessment of heart failure mortality risk.

Jennifer Cowger Matthews1, Todd F Dardas, Keith D Aaronson.   

Abstract

Heart failure (HF) presents with a wide spectrum of disease severity and with a broad risk of associated morbidity and mortality. Identification of individuals at high risk for HF death is important for assessment of candidacy for heart transplantation and mechanical circulatory assistance and, more broadly, for guiding pharmaceutical, surgical, or palliative interventions. In this article, we review and compare several of the HF risk prediction tools currently available, highlighting their clinical utilities and potential shortcomings. Risk prediction tools must be carefully selected, recognizing that their accuracy is likely to be greatest when used in patients most similar to those from whom the tool was developed. As HF is a dynamic condition, serial risk assessment at regular intervals and as patient clinical status changes is warranted, although clinical evidence to support this practice is limited.

Entities:  

Mesh:

Year:  2007        PMID: 17521503     DOI: 10.1007/s11897-007-0008-3

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  22 in total

1.  Selection of patients for heart transplantation in the current era of heart failure therapy.

Authors:  Javed Butler; Ghazanfar Khadim; Kimberly M Paul; Stacy F Davis; Marvin W Kronenberg; Don B Chomsky; Richard N Pierson; John R Wilson
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

2.  Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005.

Authors:  David O Taylor; Leah B Edwards; Mark M Boucek; Elbert P Trulock; Mario C Deng; Berkeley M Keck; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

3.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.

Authors:  K D Aaronson; J S Schwartz; T M Chen; K L Wong; J E Goin; D M Mancini
Journal:  Circulation       Date:  1997-06-17       Impact factor: 29.690

4.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

5.  Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.

Authors:  Gregg C Fonarow; Kirkwood F Adams; William T Abraham; Clyde W Yancy; W John Boscardin
Journal:  JAMA       Date:  2005-02-02       Impact factor: 56.272

6.  The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure.

Authors:  A F Osman; M R Mehra; C J Lavie; E Nunez; R V Milani
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

7.  Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.

Authors:  Lars H Lund; Keith D Aaronson; Donna M Mancini
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

8.  Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing.

Authors:  Amar L Pohwani; Srinivas Murali; Michael M Mathier; Tammy Tokarczyk; Robert L Kormos; Dennis M McNamara; Guy A MacGowan
Journal:  J Heart Lung Transplant       Date:  2003-01       Impact factor: 10.247

9.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors:  M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

10.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.